These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31487372)

  • 1. [Inflammation and Neurodegeneration in Patients with Early-Stageand Chronic Bipolar Disorder].
    Karabulut S; Taşdemir İ; Akcan U; Küçükali Cİ; Tüzün E; Çakır S
    Turk Psikiyatri Derg; 2019; 30(2):75-81. PubMed ID: 31487372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients.
    Luo Y; He H; Zhang M; Huang X; Fan N
    Psychiatry Res; 2016 Oct; 244():19-23. PubMed ID: 27455146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral inflammation during abnormal mood states in bipolar I disorder.
    Fiedorowicz JG; Prossin AR; Johnson CP; Christensen GE; Magnotta VA; Wemmie JA
    J Affect Disord; 2015 Nov; 187():172-8. PubMed ID: 26339927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
    Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
    Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder.
    Bond DJ; Andreazza AC; Hughes J; Dhanoa T; Torres IJ; Kozicky JM; Young LT; Lam RW; Yatham LN
    Psychoneuroendocrinology; 2016 Mar; 65():76-83. PubMed ID: 26731572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical staging and serum cytokines in bipolar patients during euthymia.
    Tatay-Manteiga A; Balanzá-Martínez V; Bristot G; Tabarés-Seisdedos R; Kapczinski F; Cauli O
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():194-201. PubMed ID: 28445689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.
    Lotrich FE; Butters MA; Aizenstein H; Marron MM; Reynolds CF; Gildengers AG
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):635-44. PubMed ID: 24273017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune variations in bipolar disorder: phasic differences.
    Ortiz-Domínguez A; Hernández ME; Berlanga C; Gutiérrez-Mora D; Moreno J; Heinze G; Pavón L
    Bipolar Disord; 2007 Sep; 9(6):596-602. PubMed ID: 17845274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.
    Siwek M; Sowa-Kućma M; Styczeń K; Misztak P; Nowak RJ; Szewczyk B; Dudek D; Rybakowski JK; Nowak G; Maes M
    Mol Neurobiol; 2017 Oct; 54(8):5883-5893. PubMed ID: 27660275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.
    Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF
    Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: Acute, longitudinal and therapeutic implications.
    Pantović-Stefanović M; Petronijević N; Dunjić-Kostić B; Velimirović M; Nikolić T; Jurišić V; Lačković M; Damjanović A; Totić-Poznanović S; Jovanović AA; Ivković M
    World J Biol Psychiatry; 2018; 19(sup2):S41-S51. PubMed ID: 27841086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and Interleukin-10 in mood disorders: A population-based study.
    Wiener CD; Moreira FP; Portela LV; Strogulski NR; Lara DR; da Silva RA; Souza LDM; Jansen K; Oses JP
    Psychiatry Res; 2019 Mar; 273():685-689. PubMed ID: 31207853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
    Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS
    Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of the association between pro-inflammatory cytokines and mood symptoms in bipolar disorder.
    Huang MH; Chan YE; Chen MH; Hsu JW; Huang KL; Li CT; Tsai SJ; Su TP; Bai YM
    Acta Psychiatr Scand; 2023 Jan; 147(1):81-91. PubMed ID: 36217267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder.
    Scola G; McNamara RK; Croarkin PE; Leffler JM; Cullen KR; Geske JR; Biernacka JM; Frye MA; DelBello MP; Andreazza AC
    J Affect Disord; 2016 Mar; 192():176-83. PubMed ID: 26735329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients.
    Barbosa IG; Nogueira CR; Rocha NP; Queiroz AL; Vago JP; Tavares LP; Assis F; Fagundes CT; Huguet RB; Bauer ME; Teixeira AL; de Sousa LP
    J Psychiatr Res; 2013 Dec; 47(12):1949-54. PubMed ID: 24075327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.